Guidewire devices are often used to lead or guide catheters or other interventional devices to a targeted anatomical location within a patient's body. Typically, guidewires are passed into and through a patient's vasculature in order to reach the target location, which may be at or near the patient's heart or brain, for example. Radiographic imaging is typically utilized to assist in navigating a guidewire to the targeted location. In many instances, a guidewire is placed within the body during the interventional procedure where it can be used to guide multiple catheters or other interventional devices to the targeted anatomical location.
Guidewires are available with various outer diameter sizes. Widely utilized sizes include 0.010, 0.014, 0.016, 0.018, 0.024, 0.035, and 0.038 inches, for example, though they may also be smaller or larger in diameter. Because torque transmission is a function of diameter, larger diameter guidewires typically have greater torque transmission (the ability to effectively transfer torque from proximal portions of the wire to more distal portions of the wire). On the other hand, smaller diameter guidewires typically have greater flexibility.
A catheter used in conjunction with a guidewire will be sized with an inner diameter somewhat larger than the outer diameter of the guidewire to enable the catheter to be positioned over and translated upon the guidewire. The difference in size between the guidewire and catheter can affect the ability of the catheter to travel along the guidewire. For example, the larger the annular space between the outer diameter of the guidewire and the inner diameter of the catheter, the greater the amount of potential radial offset the catheter may experience and the more difficult it may be to navigate the catheter over the guidewire. With excessive radial offset, the distal end of the catheter may have a higher risk of catching against vasculature or other anatomy of the patient rather than smoothly following along the guidewire path.
Often, a guidewire size is selected to minimize the amount of annular space between the guidewire and a given catheter size required or desired for a particular procedure, and to thereby limit the types of issues described above. However, several challenges exist to this approach. For example, increasing the size of the guidewire may overly increase the stiffness of the guidewire as well, potentially to levels that are undesirable for the initial placement of the guidewire at the targeted treatment site. Moreover, while there are known methods for increasing guidewire flexibility, such as reducing the core wire diameter, but these often come at the expense of torquability of the device.
What is needed, therefore, is a guidewire device capable of being manufactured with a relatively large outer diameter, at least at the distal section, that minimizes the annular space between the guidewire and certain sizes of compatible catheters, and that is also capable of providing sufficient flexibility and torquability along its length.
Various objects, features, characteristics, and advantages of the invention will become apparent and more readily appreciated from the following description of the embodiments, taken in conjunction with the accompanying drawings and the appended claims, all of which form a part of this specification. In the Drawings, like reference numerals may be utilized to designate corresponding or similar parts in the various Figures, and the various elements depicted are not necessarily drawn to scale, wherein:
The core 102 and the tube 104 are typically formed from different materials. For example, the tube 104 is preferably formed from a relatively flexible and elastic material such as nitinol, whereas the core 102 may be formed from a relatively less flexible and elastic material such as stainless steel. Forming the core 102 from stainless steel (or other materials with similar modulus of elasticity) may be advantageous because it allows the distal tip to hold a shape when selectively bent/shaped by an operator and because stainless steel provides sufficient modulus of elasticity to provide more responsive translational movement. While these materials are presently preferred, other suitable materials such as polymers or other metals/alloys may additionally or alternatively be utilized.
The tube 104 is coupled to the core 102 (e.g., using adhesive, soldering, and/or welding) in a manner that beneficially allows torsional forces to be transmitted from the core 102 to the tube 104 and thereby to be further transmitted distally by the tube 104. A medical grade adhesive or other suitable material may be used to couple the tube 104 to the core wire 102 at the distal end 110 of the device to form an atraumatic covering.
The outer tube 104 may include a cut pattern that forms fenestrations 106 in the tube. The pattern of fenestrations 106 may be arranged to provide desired flexibility characteristics to the tube 104, including the promotion of preferred bending directions, the reduction or elimination of preferred bending directions, or gradient increases in flexibility along the longitudinal axis, for example. Examples of cut patterns and other guidewire device features that may be utilized in the guidewire devices described herein are provided in detail in United States Patent Application Publication Nos. 2018/0193607, 2018/0071496, and 2020/0121308, the entireties of each of which are incorporated herein by this reference.
The proximal section of the guidewire device 100 (the portion extending proximally from the tube 104) extends proximally to a length necessary to provide sufficient guidewire length for delivery to a targeted anatomical area. The guidewire device 100 typically has a length ranging from about 50 cm to about 350 cm, more commonly about 200 cm, depending on particular application needs. The tube 104 may have a length ranging from about 5 cm to about 350 cm, more typically about 15 cm to about 50 cm, such as about 25 cm to about 40 cm.
The guidewire device 100 may have a diameter of about 0.010 inches to about 0.038 inches, though larger or smaller sizes may also be utilized depending on particular application needs. For example, particular embodiments may have outer diameter sizes corresponding to standard guidewire sizes such as 0.014 inches, 0.016 inches, 0.018 inches, 0.024 inches, or other such sizes common to guidewire devices. The distal section 103 of the core 102 may taper to a diameter of about 0.002 inches, or a diameter within a range of about 0.001 to 0.005 inches. In some embodiments, the distal tip may be flattened (e.g., to a rectangular cross section) to further enhance bending flexibility while minimizing reductions in cross-sectional area needed for tensile strength. In such embodiments, the cross section may have dimensions of about 0.001 inches by 0.003 inches, for example. In some embodiments, the tube 104 has a length within a range of about 3 to 350 cm.
Additional features and details regarding the foregoing components are described in further detail below. The following examples may be particularly beneficial in applications where the corresponding catheter is about sized at 0.027 inches or greater, and the guidewire is thus beneficially sized at about 0.024 inches or greater in order to limit the amount of annular space between the inner surface of the catheter and the outer surface of the guidewire, but still allow for relative movement between them. In such implementations, the guidewires described herein are able to provide sufficient diameter in the distal sections of the device to limit the annular space, while still maintaining effective torqueability and lateral flexibility. These sizes are not limiting, however, and the same features and details described below may also be utilized in guidewires that are smaller or larger than 0.024 inches.
Improved Guidewire Device with Enlarged Distal Section
The core 202 also includes a proximal section 201 (also referred to herein as the proximal core 201) that is disposed proximal of the outer tube 204 and is not inserted into the outer tube 204. The proximal core 201 may comprise a friction-lowering coating, such as polytetrafluoroethylene (PTFE) and/or other suitable coating materials. The tube 204 may also include a coating, preferably a suitable hydrophilic coating and/or other suitable coating materials.
Preferably, the outer diameter of the tube 204 is slightly larger than the outer diameter of the proximal core 201. In one exemplary embodiment, the proximal core 201 has an outer diameter of about 0.018 inches, while the tube 204 has an outer diameter of about 0.024 inches. Other core and/or tube sizes may also be utilized, however. Preferably, the tube 204 has an outer diameter that is about 10% or more larger than the outer diameter of the proximal core 201, more preferably about 15% to about 80% larger, or more preferably about 20% to about 70% larger, such as about 25% to about 35% larger.
This is further illustrated by the cross-sectional views of
As mentioned above, a larger outer diameter in the tube 204 can better match certain desired catheter sizes at the catheter distal tip portion and thereby reduce the amount of annular space between the guidewire and catheter during placement of the catheter over the guidewire. This is particularly beneficial at the more distal sections of the guidewire, which are more likely to be navigated through deeper, more tortuous portions of the patient's vasculature.
However, increasing the diameter of the core 202 to match the larger diameter of the tube 204 may make the core 202 too stiff for use in certain desired applications. Thus, maintaining a smaller core 202, while increasing the size of the tube 204 relative to the core 202, allows use of the more flexible core 202 while still enabling the benefits of a larger tube 204 at the distal sections of the guidewire 200.
As explained in more detail below, however, providing a tube 204 that has a larger outer diameter than the core 202 can introduce other challenges. In particular, the difference in diameter between the outer tube 204 and the distal core 203 enlarges the annular space between the outer surface of the distal core 203 and the inner surface of the tube 204. Because the tube 204 can be more flexible than the distal core 203, as the wire navigates a bend, the distal core 203 may be positioned off-center from the center line of the tube 204. As the guidewire is moved through the vasculature, this off-centering can disrupt the smooth distal transmission of rotational movement, causing a buildup and sudden release of forces which lead the guidewire to move with a “snap” and/or “whip” to a non-desired preferential rotational location. This disruption to the tactile feel and rotational control of the guidewire can make it more difficult for the operator to rotationally position the guidewire as intended, raising the risk of interventional procedure delays, suboptimal outcomes, inability to access the target location, or even tissue injury.
The embodiments described herein beneficially provide additional features that assist in radially centering the distal core 203 within the tube 204 even though the tube 204 has a larger outer diameter than the proximal core 201. One or more centering mechanisms may be included to beneficially reduce undesirable whip and/or snap movements of the guidewire (i.e., the centering mechanisms may improve rotational control), thereby enabling a user to have greater rotational control and improved tactile handling of the guidewire.
A bushing 212 may be included at the point forming the joint to which the proximal end of the tube 204 is attached. The bushing 212 may have an outer diameter that substantially matches the outer diameter of the proximal core 201. The bushing 212 may be formed from the same material as the tube 204 (e.g., nitinol). The bushing 212 provides for better centering between the core 202 and the tube 204 and/or reduces the amount of adhesive needed to bond the separate components. Although shown here as a tube, the bushing 212 may have alternative geometries such as a coil, braid, slotted/cut tube, etcetera.
As shown, the bushing 212 may also include a chamfered or beveled surface 214 on its proximal end to provide a smooth transition between different diameters. The distal end of the bushing 212 may also be chamfered or beveled. Even though the distal end of the bushing 212 will be covered by the tube 204, providing a bushing 212 with a chamfer/bevel on both ends can aid in manufacturing, eliminating the need to ensure proper orientation of the bushing and eliminating the potential for erroneous orientation.
The illustrated guidewire 200 includes a proximal coil 216, a distal coil 218, and a bushing coil 220 positioned over the proximal coil 216 and the distal coil 218. The distal coil 218 is preferably formed of a radiopaque material, such as platinum group, gold, silver, palladium, iridium, osmium, tantalum, tungsten, bismuth, dysprosium, gadolinium, and the like. The distal coil 218 thus preferably allows radiographic visualization of the distal end of the guidewire 200 during a procedure. The distal coil 218 may have a length of about 0.5 cm to about 20 cm, or more typically about 3 cm to about 15 cm, such as about 10 cm.
The proximal coil 216 may be formed from a non-radiopaque material such as stainless steel, other suitable metal, a suitable polymer, or other suitable material. The proximal coil 216 may be attached to the distal core 203 at a point adjacent to or near to the proximal end of the distal coil 218 and/or at any point along the coincident length of the distal core 203, most commonly at or near each end of the proximal coil 216. The proximal coil 216 may have a length of about 1 to 25 cm, or more typically about 3 to 20 cm, such as about 5 to 15 cm. Technically, the distal coil 218 could be extended further proximally to take the place of the proximal coil 216. However, materials that function well as radiopaque markers (e.g., platinum) are relatively expensive. Also, their use as a packing material to fill large portions of the annular space could cause the distal section of the guidewire 200 to be overly bright when imaged under x-ray fluoroscopy and thus not allow the operator to visualize other areas of interest. Thus, the proximal coil 216 is preferably separate from, and formed from a different material than, the distal coil 218.
The proximal coil 216 and the distal coil 218 aid in filling some of the annular space between the distal core 203 and the tube 204. Although the coil examples illustrated herein are shown having wires with a circular cross section, it will be understood that other coil types may also be utilized. For example, centering coil(s) may be edge-wound and/or may have a ribbon, rectangular, oblong, or other non-circular shaped cross-sectional shape.
Although the proximal coil 216 and distal coil 218 aid in filling some of the annular space, additional annular space remains, particularly when a somewhat larger tube 204 is utilized. The wire size of the proximal coil 216 and distal coil 218 could be increased to fill more space. However, increasing wire size too much may introduce excessive stiffness to the device. Preferably, the wire size of the proximal coil 216 and distal coil 218 is about 0.008 inches or less, or about 0.006 inches or less, or more preferably about 0.004 inches or less, such as about 0.002 inches or less.
To aid in filling the remainder of the annular space, the guidewire 200 may include a bushing coil 220. The bushing coil 220 may be disposed over the proximal coil 216 and the distal coil 218. The bushing coil 220 may extend over the entirety of both of the proximal coil 216 and the distal coil 218. As with the proximal coil 216 and the distal coil 218, the wire diameter of the bushing coil 220 is preferably limited. For example, the wire diameter of the bushing coil may be about 0.008 inches or less, or about 0.006 inches or less, or more preferably about 0.004 inches or less, such as about 0.002 inches or less. The bushing coil 220 may be formed of stainless steel and/or other suitable material, such as another metal or a polymer.
The use of a bushing coil 220 in addition to the proximal coil 216 and distal coil 218 aids in filling the annular space between the distal core 203 and the tube 204 without the use of over-sized coils. This aids in maintaining centering of the distal core 203 within the tube 204, which prevents the undesirable effects of misalignment that have been described above while also minimally impacting the bending flexibility of the device.
In some embodiments, the bushing coil 220 may be substantially coincident with the proximal coil 216 and the distal coil 218. Alternatively, as shown, the bushing coil 220 may extend farther proximally than the proximal coil 216. This allows the bushing coil 220 to fill in more of the annular space even at portions where the proximal coil 216 is not able. That is, because of the tapered profile of the distal core 203, certain more proximal portions of the annular space do not fit both the proximal coil 216 and the bushing coil 220, but may still be filled by the further extending proximal portion of the bushing coil 220. The bushing coil 220 preferably extends along a substantial portion of the length of the tube 204. For example, the bushing coil 220 may have a length of at least about 60% of the length of the tube 204, or at least about 75% of the length of the tube 204, or at least about 80% of the length of the tube 204, or at least about 85% of the length of the tube 204.
In preferred embodiments, the proximal coil 216 and the distal coil 218 are each wound in a first direction, while the bushing coil 220 is counter-wound in a second, opposite direction. This beneficially limits interlocking and binding of the bushing coil 220 to either of the proximal coil 216 or the distal coil 218. The bushing coil 220 may also have a pitch that is different (e.g., narrower) than that of the proximal coil 216 or the distal coil 218. For example, the proximal coil 216 and/or the distal coil 218 may have a pitch of about 0.002 inches to about 0.008 inches, or about 0.003 inches to about 0.007 inches, whereas the bushing coil 220 may have a pitch of about 0.001 inches to about 0.006 inches, or about 0.002 inches to about 0.005 inches.
The proximal coil 216, the distal coil 218, and the bushing coil 220 are preferably configured to fill a substantial portion of the volume of the annular space between the distal core 203 and the tube 204. For example, proximal coil 216, the distal coil 218, and the bushing coil 220 may be configured to fill approximately 20% or more, 35% or more, 50% or more, 60% or more, 70% or more, 80% or more, or even up to about 90% or more of the volume of the annular space. Of course, other conventional guidewires may include joints or bushings that fill up large portions of the annular space at the particular part of the guidewire they are located. However, when the entire length of the outer tube is considered, such joints and bushings fill relatively little of the volume of the overall annular space.
The centering mechanism principles described herein may be utilized with other structural configurations to provide beneficial centering effects. For example, while the above embodiments describe various centering mechanisms with a core as the “inner member” and a microfabricated tube as the “outer member,” other structures may additionally or alternatively be utilized as the outer and/or inner members along with one or more of the described centering mechanisms.
For example, the inner member may be a wire (such as a ground core as described above), a tube (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), a braid, or a coil. By way of further example, the outer member may be a tube (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), a braid, a coil, or a polymer tube impregnated with a braid or coil. The centering mechanism may include a set of coils such as those described above, or may additionally or alternatively include other structures for providing centering of the inner member within the outer member. For example, one or more of the coils 216, 218, 220 may be replaced by one or more tubes (e.g., metal or polymer hypotube or metal or polymer microfabricated tube), braided sections, or sets of stacked rings.
The illustrated embodiment, for example, may include a three-beam section 230 (three beams connecting each adjacent pair of rings) that transitions to a two-beam section 232 (two beams connecting each adjacent pair of rings) that transitions to a one-beam section 234 (a single beam connecting each adjacent pair of rings). Within each of these sections, the cut depth and/or cut spacing may also be adjusted to provide a smooth intra-section and inter-section flexibility gradient. For example, the two-beam section 232 may have progressively less distance between cuts as it advances toward the distal end 224. It may then transition to the one-beam section 234, which itself then includes progressively less distance between cuts as it advances toward the distal end 224.
The one-beam section 234 may have a length of about 0.5 cm to about 3 cm, or about 0.75 cm to about 2 cm, for example. The two-beam section 232 may have a length of about 4 cm to about 16 cm, or about 6 cm to about 12 cm, for example. The three-beam section 230 may have a length of about 12 cm to about 36 cm, or about 18 cm to about 30 cm, for example. In other words, the three-beam section 230 may be about 2 to 5 times longer than the two-beam section 232, and the two-beam section 232 may be about 2 to 5 times longer than the one-beam section 234. Designing the tube 204 with these proportions of cut/beam sections has been found to provide effective balance of axial, lateral, and torsional stiffness for most applications.
The tube 204 may also include a distal-most section 235 that has a two-beam pattern. This section is preferably relatively short, such as about 0.5 cm or less, or about 0.25 cm or less, or about 0.15 cm or less. Providing a relatively short two-beam section at section 235 provides added surface area for an adhesive material applied at or near the distal end 224 of the tube 204 to bond, allowing a stronger coupling between the distal end 224 and any internal components bonded thereto.
Certain sections of the tube 204 may have cuts that are rotationally offset so as to avoid the formation of any preferred bending planes. For example, an angular offset may be applied after each cut or series of cuts such that the overall resulting pattern of beams 226 in the tube 204 do not align in a way that forms preferred bending planes.
Other sections of the tube 204 may include a preferred bending plane. For example, the one-beam section 234 may be aligned as shown in
While certain embodiments of the present disclosure have been described in detail, with reference to specific configurations, parameters, components, elements, etcetera, the descriptions are illustrative and are not to be construed as limiting the scope of the claimed invention.
Furthermore, it should be understood that for any given element of component of a described embodiment, any of the possible alternatives listed for that element or component may generally be used individually or in combination with one another, unless implicitly or explicitly stated otherwise.
In addition, unless otherwise indicated, numbers expressing quantities, constituents, distances, or other measurements used in the specification and claims are to be understood as optionally being modified by the term “about” or its synonyms. When the terms “about,” “approximately,” “substantially,” or the like are used in conjunction with a stated amount, value, or condition, it may be taken to mean an amount, value or condition that deviates by less than 20%, less than 10%, less than 5%, or less than 1% of the stated amount, value, or condition. At the very least, and not as an attempt to limit the application of the doctrine of equivalents to the scope of the claims, each numerical parameter should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
Any headings and subheadings used herein are for organizational purposes only and are not meant to be used to limit the scope of the description or the claims.
It will also be noted that, as used in this specification and the appended claims, the singular forms “a,” “an” and “the” do not exclude plural referents unless the context clearly dictates otherwise. Thus, for example, an embodiment referencing a singular referent (e.g., “widget”) may also include two or more such referents.
It will also be appreciated that embodiments described herein may include properties, features (e.g., ingredients, components, members, elements, parts, and/or portions) described in other embodiments described herein. Accordingly, the various features of a given embodiment can be combined with and/or incorporated into other embodiments of the present disclosure. Thus, disclosure of certain features relative to a specific embodiment of the present disclosure should not be construed as limiting application or inclusion of said features to the specific embodiment. Rather, it will be appreciated that other embodiments can also include such features.
This application claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/965,005, filed Jan. 23, 2020 and titled “Guidewire Having Enlarged, Micro-Fabricated Distal Section”, the entirety of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2022065 | Wappler | Nov 1935 | A |
2187299 | Otto | Jan 1940 | A |
3183702 | Zittell | May 1965 | A |
3572334 | Petterson | Mar 1971 | A |
3612058 | Ackerman | Oct 1971 | A |
3709271 | Flory | Jan 1973 | A |
3782233 | Helm | Jan 1974 | A |
3920058 | Walker | Nov 1975 | A |
4163406 | Crawford | Aug 1979 | A |
4239069 | Zimmerman | Dec 1980 | A |
4416312 | Destberg | Nov 1983 | A |
4688540 | Ono | Aug 1987 | A |
4719924 | Crittenden et al. | Jan 1988 | A |
4801297 | Mueller | Jan 1989 | A |
4846186 | Box et al. | Jul 1989 | A |
4895168 | Machek | Jan 1990 | A |
4989608 | Ratner | Feb 1991 | A |
5047045 | Arney et al. | Sep 1991 | A |
5069217 | Fleischhacker, Jr. | Dec 1991 | A |
5084022 | Claude | Jan 1992 | A |
5095915 | Engelson | Mar 1992 | A |
5102390 | Crittenden et al. | Apr 1992 | A |
5144959 | Gambale et al. | Sep 1992 | A |
5147317 | Shank et al. | Sep 1992 | A |
5154725 | Leopold | Oct 1992 | A |
5174302 | Palmer | Dec 1992 | A |
5315996 | Lundquist | May 1994 | A |
5326374 | Ilbawi et al. | Jul 1994 | A |
5345945 | Hodgson et al. | Sep 1994 | A |
5372587 | Hammerslag et al. | Dec 1994 | A |
5381782 | Delarama et al. | Jan 1995 | A |
5382259 | Phelps et al. | Jan 1995 | A |
5385152 | Abele et al. | Jan 1995 | A |
5437288 | Schwartz et al. | Aug 1995 | A |
5441483 | Avitall | Aug 1995 | A |
D363544 | Rowland et al. | Oct 1995 | S |
D363776 | Rowland et al. | Oct 1995 | S |
5506682 | Pryor | Apr 1996 | A |
5507751 | Goode et al. | Apr 1996 | A |
5551444 | Finlayson | Sep 1996 | A |
5554114 | Wallace et al. | Sep 1996 | A |
5569218 | Berg | Oct 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5573867 | Zafred et al. | Nov 1996 | A |
5606981 | Tartacower et al. | Mar 1997 | A |
5659205 | Weisser | Aug 1997 | A |
5673707 | Chandrasekaran | Oct 1997 | A |
5676659 | McGurk | Oct 1997 | A |
5685568 | Pirrello | Nov 1997 | A |
5685868 | Lundquist | Nov 1997 | A |
5690120 | Jacobsen et al. | Nov 1997 | A |
5706826 | Schwager | Jan 1998 | A |
5741429 | Donadio et al. | Apr 1998 | A |
5746701 | Noone | May 1998 | A |
5792154 | Doan et al. | Aug 1998 | A |
5797857 | Obitsu | Aug 1998 | A |
5800454 | Jacobsen et al. | Sep 1998 | A |
5833631 | Nguyen | Nov 1998 | A |
5833632 | Jacobsen et al. | Nov 1998 | A |
5842461 | Azuma | Dec 1998 | A |
5860963 | Azam et al. | Jan 1999 | A |
5876356 | Viera et al. | Mar 1999 | A |
5911715 | Berg et al. | Jun 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5916194 | Jacobsen et al. | Jun 1999 | A |
5931830 | Jacobsen et al. | Aug 1999 | A |
5954672 | Schwager | Sep 1999 | A |
6004279 | Crowley et al. | Dec 1999 | A |
6014919 | Jacobsen | Jan 2000 | A |
6017319 | Jacobsen et al. | Jan 2000 | A |
6022343 | Johnson et al. | Feb 2000 | A |
6022369 | Jacobsen et al. | Feb 2000 | A |
6027863 | Donadio, III | Feb 2000 | A |
6033288 | Weisshaus et al. | Mar 2000 | A |
6033394 | Vidlund et al. | Mar 2000 | A |
6056702 | Lorenzo | May 2000 | A |
6063101 | Jacobsen et al. | May 2000 | A |
6110164 | Vidlund | Aug 2000 | A |
6132389 | Cornish et al. | Oct 2000 | A |
6139511 | Huter et al. | Oct 2000 | A |
D435909 | Ogino et al. | Jan 2001 | S |
6168570 | Ferrera | Jan 2001 | B1 |
6179828 | Mottola et al. | Jan 2001 | B1 |
6183410 | Jacobsen et al. | Feb 2001 | B1 |
6183420 | Douk et al. | Feb 2001 | B1 |
6214042 | Jacobsen et al. | Apr 2001 | B1 |
6228073 | Noone et al. | May 2001 | B1 |
6245030 | Dubois et al. | Jun 2001 | B1 |
6251086 | Cornelius et al. | Jun 2001 | B1 |
6260458 | Jacobsen et al. | Jul 2001 | B1 |
6261246 | Pantages et al. | Jul 2001 | B1 |
6273881 | Kiemeneij | Aug 2001 | B1 |
6302870 | Jacobsen et al. | Oct 2001 | B1 |
6306105 | Rooney et al. | Oct 2001 | B1 |
6346091 | Jacobsen et al. | Feb 2002 | B1 |
6356791 | Westlund et al. | Mar 2002 | B1 |
6402706 | Richardson et al. | Jun 2002 | B2 |
6428489 | Jacobsen et al. | Aug 2002 | B1 |
6431039 | Jacobsen et al. | Aug 2002 | B1 |
6436056 | Wang et al. | Aug 2002 | B1 |
6440088 | Jacobsen et al. | Aug 2002 | B1 |
6458867 | Wang et al. | Oct 2002 | B1 |
6464651 | Hiejima et al. | Oct 2002 | B1 |
6492615 | Flanagan | Dec 2002 | B1 |
6494894 | Mirarchi | Dec 2002 | B2 |
6527732 | Strauss et al. | Mar 2003 | B1 |
6527746 | Oslund et al. | Mar 2003 | B1 |
6553880 | Jacobsen et al. | Apr 2003 | B2 |
6554820 | Wendlandt et al. | Apr 2003 | B1 |
6558355 | Metzger et al. | May 2003 | B1 |
6579246 | Jacobsen et al. | Jun 2003 | B2 |
6602207 | Mam et al. | Aug 2003 | B1 |
6606985 | Negishi | Aug 2003 | B2 |
6610046 | Usami et al. | Aug 2003 | B1 |
6627724 | Meijs et al. | Sep 2003 | B2 |
6652508 | Griffin et al. | Nov 2003 | B2 |
6671560 | Westlund et al. | Dec 2003 | B2 |
6766720 | Jacobsen et al. | Jul 2004 | B1 |
6805676 | Klint | Oct 2004 | B2 |
6866642 | Kellerman et al. | Mar 2005 | B2 |
RE39018 | Azuma et al. | Mar 2006 | E |
7024885 | Villalobos | Apr 2006 | B2 |
7097624 | Campion et al. | Aug 2006 | B2 |
7110910 | Deffenbaugh et al. | Sep 2006 | B1 |
7128718 | Hojeibane et al. | Oct 2006 | B2 |
7172587 | Poole et al. | Feb 2007 | B2 |
7182735 | Shireman et al. | Feb 2007 | B2 |
7276062 | McDaniel et al. | Oct 2007 | B2 |
7338345 | Fujinami | Mar 2008 | B2 |
7421929 | French | Sep 2008 | B2 |
7494474 | Richardson et al. | Feb 2009 | B2 |
7507246 | McGuckin et al. | Mar 2009 | B2 |
D598094 | Alber | Aug 2009 | S |
7621880 | Ryan et al. | Nov 2009 | B2 |
7637875 | Itou | Dec 2009 | B2 |
7641622 | Satou et al. | Jan 2010 | B2 |
D611596 | Kousai et al. | Mar 2010 | S |
7670302 | Griffin et al. | Mar 2010 | B2 |
7699792 | Hofmann et al. | Apr 2010 | B2 |
7722545 | Bertsch | May 2010 | B2 |
7722552 | Aimi et al. | May 2010 | B2 |
7744545 | Aimi et al. | Jun 2010 | B2 |
7747314 | Parins et al. | Jun 2010 | B2 |
7753859 | Kinoshita et al. | Jul 2010 | B2 |
7766896 | Kornkven et al. | Aug 2010 | B2 |
7769839 | Boivie et al. | Aug 2010 | B2 |
7785273 | Eskuri | Aug 2010 | B2 |
7789839 | Lupton | Sep 2010 | B2 |
7806837 | Rasmussen et al. | Oct 2010 | B2 |
7878984 | Jacobsen et al. | Feb 2011 | B2 |
7883474 | Mirigian et al. | Feb 2011 | B1 |
7914467 | Ayman et al. | Mar 2011 | B2 |
7942832 | Kanuka et al. | May 2011 | B2 |
7989042 | Obara et al. | Aug 2011 | B2 |
8007434 | Olson | Aug 2011 | B2 |
8043314 | Noriega et al. | Oct 2011 | B2 |
8048004 | Davis et al. | Nov 2011 | B2 |
8092444 | Lentz et al. | Jan 2012 | B2 |
8105246 | Voeller et al. | Jan 2012 | B2 |
8128579 | Chen et al. | Mar 2012 | B2 |
8128580 | Fujimagari et al. | Mar 2012 | B2 |
8137293 | Zhou et al. | Mar 2012 | B2 |
8167821 | Sharrow | May 2012 | B2 |
8257279 | Jacobsen | Sep 2012 | B2 |
8292827 | Musbach et al. | Oct 2012 | B2 |
8292828 | Bernhard | Oct 2012 | B2 |
8357140 | Majercak et al. | Jan 2013 | B2 |
8376865 | Forster et al. | Feb 2013 | B2 |
8376961 | Layman et al. | Feb 2013 | B2 |
8377056 | Oyola et al. | Feb 2013 | B2 |
8409114 | Parins | Apr 2013 | B2 |
8409169 | Moss | Apr 2013 | B1 |
8444577 | Bunch et al. | May 2013 | B2 |
8454535 | Majercak et al. | Jun 2013 | B2 |
8460213 | Northrop | Jun 2013 | B2 |
8465469 | Brightbill | Jun 2013 | B2 |
8468919 | Christian et al. | Jun 2013 | B2 |
8500658 | Boyle et al. | Aug 2013 | B2 |
8517959 | Kurosawa et al. | Aug 2013 | B2 |
8535243 | Shireman | Sep 2013 | B2 |
8540648 | Bernhard | Sep 2013 | B2 |
8540668 | Griffin et al. | Sep 2013 | B2 |
8551020 | Chen et al. | Oct 2013 | B2 |
8551021 | Voeller et al. | Oct 2013 | B2 |
8556914 | Vrba | Oct 2013 | B2 |
8585643 | Vo et al. | Nov 2013 | B2 |
8622931 | Teague et al. | Jan 2014 | B2 |
8622933 | Maki et al. | Jan 2014 | B2 |
8728075 | Wu et al. | May 2014 | B2 |
8758269 | Miyata et al. | Jun 2014 | B2 |
8784337 | Voeller et al. | Jul 2014 | B2 |
8795202 | Northrop et al. | Aug 2014 | B2 |
8795254 | Layman et al. | Aug 2014 | B2 |
8821477 | Northrop et al. | Sep 2014 | B2 |
8870790 | Davis et al. | Oct 2014 | B2 |
8900163 | Jacobsen et al. | Dec 2014 | B2 |
8915865 | Jacobsen et al. | Dec 2014 | B2 |
8932235 | Jacobsen et al. | Jan 2015 | B2 |
8936558 | Jacobsen et al. | Jan 2015 | B2 |
8939916 | Jacobsen et al. | Jan 2015 | B2 |
8956310 | Miyata et al. | Feb 2015 | B2 |
9011511 | Gregorich et al. | Apr 2015 | B2 |
9067332 | Lippert et al. | Jun 2015 | B2 |
9067333 | Lippert et al. | Jun 2015 | B2 |
9072873 | Lippert et al. | Jul 2015 | B2 |
9072874 | Northrop et al. | Jul 2015 | B2 |
D742000 | Kanazawa | Oct 2015 | S |
9162040 | Vo et al. | Oct 2015 | B2 |
9227037 | Northrop | Jan 2016 | B2 |
9364589 | Cage et al. | Jun 2016 | B2 |
9375234 | Vrba | Jun 2016 | B2 |
9433762 | Griffin et al. | Sep 2016 | B2 |
9439557 | Boulais | Sep 2016 | B2 |
9550013 | Kawasaki | Jan 2017 | B2 |
9616195 | Lippert et al. | Apr 2017 | B2 |
9623212 | Tano et al. | Apr 2017 | B2 |
9662798 | Christian et al. | May 2017 | B2 |
9700702 | Tano et al. | Jul 2017 | B2 |
9808595 | Turnlund et al. | Nov 2017 | B2 |
9839764 | Chouinard | Dec 2017 | B2 |
9848882 | Lippert | Dec 2017 | B2 |
D809138 | Khan et al. | Jan 2018 | S |
9950137 | Lippert et al. | Apr 2018 | B2 |
9999748 | Cajamarca et al. | Jun 2018 | B2 |
10028666 | Gregorich | Jul 2018 | B2 |
10052013 | Boulais | Aug 2018 | B2 |
10149608 | Fujitani | Dec 2018 | B2 |
D839426 | Bajwa | Jan 2019 | S |
D847335 | Kuwada | Apr 2019 | S |
10252024 | Northrop | Apr 2019 | B2 |
D855180 | Haefliger | Jul 2019 | S |
10350383 | Shuman | Jul 2019 | B2 |
10363389 | Lippert et al. | Jul 2019 | B2 |
D855800 | Gabay et al. | Aug 2019 | S |
10420537 | Salahieh et al. | Sep 2019 | B2 |
10456556 | Cabiri | Oct 2019 | B2 |
10639456 | Peralta | May 2020 | B2 |
10675444 | Kauphusman et al. | Jun 2020 | B2 |
10758710 | Romano | Sep 2020 | B2 |
10806893 | Jaroch | Oct 2020 | B2 |
11007345 | Cottone | May 2021 | B2 |
11052226 | Salahieh et al. | Jul 2021 | B2 |
11052228 | Lippert | Jul 2021 | B2 |
11141566 | Cabiri | Oct 2021 | B2 |
D946148 | Takemoto | Mar 2022 | S |
11278704 | Pleijers | Mar 2022 | B2 |
11471645 | McNiven et al. | Oct 2022 | B2 |
11497512 | Wallace et al. | Nov 2022 | B2 |
11565093 | Kirt et al. | Jan 2023 | B2 |
D980427 | Method et al. | Mar 2023 | S |
11679236 | Von et al. | Jun 2023 | B2 |
11724065 | Tilson et al. | Aug 2023 | B2 |
11724068 | Von et al. | Aug 2023 | B2 |
11759217 | Keating et al. | Sep 2023 | B2 |
11766539 | Yee et al. | Sep 2023 | B2 |
D1014751 | Shih | Feb 2024 | S |
11918753 | Moquin et al. | Mar 2024 | B2 |
11957312 | Boulais | Apr 2024 | B2 |
20010009980 | Richardson et al. | Jul 2001 | A1 |
20010044624 | Seraj et al. | Nov 2001 | A1 |
20020013540 | Jacobsen et al. | Jan 2002 | A1 |
20020019599 | Rooney et al. | Feb 2002 | A1 |
20020049392 | Demello | Apr 2002 | A1 |
20020062524 | Vogland et al. | May 2002 | A1 |
20020068912 | Merdan | Jun 2002 | A1 |
20020078808 | Jacobsen et al. | Jun 2002 | A1 |
20020082524 | Anderson et al. | Jun 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20030023190 | Cox | Jan 2003 | A1 |
20030060732 | Jacobsen et al. | Mar 2003 | A1 |
20030069521 | Reynolds et al. | Apr 2003 | A1 |
20030069522 | Jacobsen et al. | Apr 2003 | A1 |
20030093059 | Griffin et al. | May 2003 | A1 |
20030125641 | Jafari et al. | Jul 2003 | A1 |
20040039371 | Tockman et al. | Feb 2004 | A1 |
20040054349 | Brightbill | Mar 2004 | A1 |
20040087933 | Lee et al. | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040102719 | Keith et al. | May 2004 | A1 |
20040102720 | Kellerman et al. | May 2004 | A1 |
20040111044 | Davis et al. | Jun 2004 | A1 |
20040122340 | Vrba | Jun 2004 | A1 |
20040167437 | Sharrow et al. | Aug 2004 | A1 |
20040167440 | Sharrow | Aug 2004 | A1 |
20040167443 | Shireman et al. | Aug 2004 | A1 |
20040171996 | Kiemeneij | Sep 2004 | A1 |
20040181174 | Davis et al. | Sep 2004 | A2 |
20040186485 | Kear | Sep 2004 | A1 |
20040193140 | Griffin et al. | Sep 2004 | A1 |
20040225292 | Sasso et al. | Nov 2004 | A1 |
20040254450 | Griffin et al. | Dec 2004 | A1 |
20050054953 | Ryan et al. | Mar 2005 | A1 |
20050065456 | Eskuri | Mar 2005 | A1 |
20050124976 | Devens et al. | Jun 2005 | A1 |
20050137501 | Euteneuer et al. | Jun 2005 | A1 |
20050216049 | Jones et al. | Sep 2005 | A1 |
20050274384 | Tran et al. | Dec 2005 | A1 |
20060006649 | Galdonik et al. | Jan 2006 | A1 |
20060041186 | Vancaillie | Feb 2006 | A1 |
20060074442 | Noriega et al. | Apr 2006 | A1 |
20060089618 | McFerran et al. | Apr 2006 | A1 |
20060112802 | Fujinami | Jun 2006 | A1 |
20060121218 | Obara et al. | Jun 2006 | A1 |
20060189896 | Davis et al. | Aug 2006 | A1 |
20060241519 | Hojeibane et al. | Oct 2006 | A1 |
20060247661 | Richards et al. | Nov 2006 | A1 |
20060262474 | Chen et al. | Nov 2006 | A1 |
20070010786 | Casey et al. | Jan 2007 | A1 |
20070055302 | Henry et al. | Mar 2007 | A1 |
20070100285 | Griffin et al. | May 2007 | A1 |
20070112331 | Weber et al. | May 2007 | A1 |
20070135763 | Musbach et al. | Jun 2007 | A1 |
20070142893 | Buiser et al. | Jun 2007 | A1 |
20070167876 | Euteneuer et al. | Jul 2007 | A1 |
20070185415 | Ressemann et al. | Aug 2007 | A1 |
20070221230 | Thompson et al. | Sep 2007 | A1 |
20070233039 | Mitelberg | Oct 2007 | A1 |
20070250036 | Volk et al. | Oct 2007 | A1 |
20070282270 | Mathews et al. | Dec 2007 | A1 |
20070287955 | Layman et al. | Dec 2007 | A1 |
20080021347 | Jacobsen et al. | Jan 2008 | A1 |
20080021401 | Jacobsen | Jan 2008 | A1 |
20080021404 | Jacobsen et al. | Jan 2008 | A1 |
20080021406 | Jacobsen et al. | Jan 2008 | A1 |
20080064989 | Chen et al. | Mar 2008 | A1 |
20080077049 | Hirshman | Mar 2008 | A1 |
20080086854 | Boyd et al. | Apr 2008 | A1 |
20080097246 | Stafford | Apr 2008 | A1 |
20080097247 | Eskuri | Apr 2008 | A1 |
20080097248 | Munoz et al. | Apr 2008 | A1 |
20080114303 | Tremaglio | May 2008 | A1 |
20080119869 | Teague et al. | May 2008 | A1 |
20080122226 | Madison | May 2008 | A1 |
20080125674 | Bilecen et al. | May 2008 | A1 |
20080147170 | Vrba | Jun 2008 | A1 |
20080188298 | Seelig et al. | Aug 2008 | A1 |
20080188928 | Salahieh et al. | Aug 2008 | A1 |
20080200839 | Bunch et al. | Aug 2008 | A1 |
20080262474 | Northrop | Oct 2008 | A1 |
20080269641 | O'Shaughnessy et al. | Oct 2008 | A1 |
20080319525 | Tieu et al. | Dec 2008 | A1 |
20090036832 | Skujins et al. | Feb 2009 | A1 |
20090036833 | Parins | Feb 2009 | A1 |
20090043283 | Turnlund et al. | Feb 2009 | A1 |
20090043372 | Northrop et al. | Feb 2009 | A1 |
20090118675 | Czyscon et al. | May 2009 | A1 |
20090118704 | Sharrow et al. | May 2009 | A1 |
20090177119 | Heidner et al. | Jul 2009 | A1 |
20090177185 | Northrop | Jul 2009 | A1 |
20090254000 | Layman | Oct 2009 | A1 |
20090292225 | Chen et al. | Nov 2009 | A1 |
20090318892 | Aboytes et al. | Dec 2009 | A1 |
20100063479 | Merdan et al. | Mar 2010 | A1 |
20100069882 | Jennings | Mar 2010 | A1 |
20100114017 | Lenker et al. | May 2010 | A1 |
20100114302 | Tzafriri et al. | May 2010 | A1 |
20100139465 | Christian et al. | Jun 2010 | A1 |
20100145308 | Layman et al. | Jun 2010 | A1 |
20100228150 | Zimmerman et al. | Sep 2010 | A1 |
20100256527 | Lippert et al. | Oct 2010 | A1 |
20100256528 | Lippert et al. | Oct 2010 | A1 |
20100256601 | Lippert et al. | Oct 2010 | A1 |
20100256602 | Lippert et al. | Oct 2010 | A1 |
20100256603 | Lippert et al. | Oct 2010 | A1 |
20100256604 | Lippert et al. | Oct 2010 | A1 |
20100256605 | Lippert et al. | Oct 2010 | A1 |
20100256606 | Lippert et al. | Oct 2010 | A1 |
20100318066 | Miyata et al. | Dec 2010 | A1 |
20110011226 | Tsurusawa et al. | Jan 2011 | A1 |
20110022003 | Tekulve | Jan 2011 | A1 |
20110160680 | Cage et al. | Jun 2011 | A1 |
20110245807 | Sakata et al. | Oct 2011 | A1 |
20110245808 | Voeller et al. | Oct 2011 | A1 |
20110251519 | Romoscanu | Oct 2011 | A1 |
20110313417 | De et al. | Dec 2011 | A1 |
20120046575 | Brown | Feb 2012 | A1 |
20120065623 | Nelson et al. | Mar 2012 | A1 |
20120158034 | Wilson et al. | Jun 2012 | A1 |
20120209073 | McWeeney et al. | Aug 2012 | A1 |
20120239074 | Aboytes et al. | Sep 2012 | A1 |
20120271397 | Muzslay et al. | Oct 2012 | A1 |
20120289938 | Northrop et al. | Nov 2012 | A1 |
20130018280 | Tano et al. | Jan 2013 | A1 |
20130018359 | Coyle | Jan 2013 | A1 |
20130096553 | Hill et al. | Apr 2013 | A1 |
20130110000 | Tully et al. | May 2013 | A1 |
20130131642 | Miyata et al. | May 2013 | A1 |
20130144267 | Chan et al. | Jun 2013 | A1 |
20130184703 | Shireman et al. | Jul 2013 | A1 |
20130226033 | Eskuri | Aug 2013 | A1 |
20130255456 | Christian et al. | Oct 2013 | A1 |
20140012281 | Wang et al. | Jan 2014 | A1 |
20140031719 | Kanazawa | Jan 2014 | A1 |
20140058324 | Salahieh et al. | Feb 2014 | A1 |
20140094787 | Reynolds | Apr 2014 | A1 |
20140187983 | Anderson | Jul 2014 | A1 |
20140257363 | Lippert | Sep 2014 | A1 |
20140276109 | Gregorich | Sep 2014 | A1 |
20140276787 | Wang et al. | Sep 2014 | A1 |
20140279109 | Vasquez et al. | Sep 2014 | A1 |
20140309657 | Ben-Ami | Oct 2014 | A1 |
20140336620 | Ayman et al. | Nov 2014 | A1 |
20150011834 | Ayala et al. | Jan 2015 | A1 |
20150011964 | Abner et al. | Jan 2015 | A1 |
20150057639 | Storbeck et al. | Feb 2015 | A1 |
20150190614 | Bernhard | Jul 2015 | A1 |
20150190615 | Shaltis | Jul 2015 | A1 |
20150216533 | Gray et al. | Aug 2015 | A1 |
20150238734 | Kanazawa | Aug 2015 | A1 |
20150290432 | Mathews et al. | Oct 2015 | A1 |
20150297863 | Hannon et al. | Oct 2015 | A1 |
20150305710 | Stigall et al. | Oct 2015 | A1 |
20150306355 | Idstrom | Oct 2015 | A1 |
20160001048 | Koike | Jan 2016 | A1 |
20160008585 | Tano | Jan 2016 | A1 |
20160045101 | Nakatate et al. | Feb 2016 | A1 |
20160058382 | Burkett et al. | Mar 2016 | A1 |
20160089128 | Weber et al. | Mar 2016 | A1 |
20160113793 | Nishigishi | Apr 2016 | A1 |
20160135827 | Elsesser et al. | May 2016 | A1 |
20160199620 | Pokorney et al. | Jul 2016 | A1 |
20160235337 | Govari et al. | Aug 2016 | A1 |
20160287054 | Fujitani | Oct 2016 | A1 |
20160310702 | Cabiri | Oct 2016 | A1 |
20160361520 | Braun | Dec 2016 | A1 |
20160367788 | Jimenez et al. | Dec 2016 | A1 |
20160375226 | Nabeshima et al. | Dec 2016 | A1 |
20170047740 | Narla | Feb 2017 | A1 |
20170049594 | Banas et al. | Feb 2017 | A1 |
20170136213 | Kauphusman et al. | May 2017 | A1 |
20170189643 | Christian et al. | Jul 2017 | A1 |
20170203076 | Groneberg et al. | Jul 2017 | A1 |
20170215954 | Datta et al. | Aug 2017 | A1 |
20170234411 | Dewaele et al. | Aug 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20180015260 | Sano et al. | Jan 2018 | A1 |
20180015261 | Lippert | Jan 2018 | A1 |
20180015262 | Lippert et al. | Jan 2018 | A1 |
20180015263 | Lippert et al. | Jan 2018 | A1 |
20180028177 | Van et al. | Feb 2018 | A1 |
20180071496 | Snyder et al. | Mar 2018 | A1 |
20180177517 | Lippert et al. | Jun 2018 | A1 |
20180185619 | Batman et al. | Jul 2018 | A1 |
20180193603 | Falb et al. | Jul 2018 | A1 |
20180193607 | Lippert et al. | Jul 2018 | A1 |
20180207407 | Tanigaki | Jul 2018 | A1 |
20190008639 | Landon et al. | Jan 2019 | A1 |
20190105463 | Christian et al. | Apr 2019 | A1 |
20190175869 | Kirt et al. | Jun 2019 | A1 |
20190255290 | Snyder et al. | Aug 2019 | A1 |
20190290883 | Lippert et al. | Sep 2019 | A1 |
20190358434 | Fuller et al. | Nov 2019 | A1 |
20200016378 | Williams et al. | Jan 2020 | A1 |
20200054860 | McElhaney et al. | Feb 2020 | A1 |
20200094027 | Davis | Mar 2020 | A1 |
20200121308 | Davis et al. | Apr 2020 | A1 |
20200222666 | Chan et al. | Jul 2020 | A1 |
20200222672 | Davis et al. | Jul 2020 | A1 |
20200330734 | Sugita et al. | Oct 2020 | A1 |
20200345975 | Snyder | Nov 2020 | A1 |
20210022748 | Lorenzo | Jan 2021 | A1 |
20210162184 | Lippert et al. | Jun 2021 | A1 |
20210178128 | Lippert et al. | Jun 2021 | A1 |
20210213241 | Christian et al. | Jul 2021 | A1 |
20210283372 | Murphy | Sep 2021 | A1 |
20210283380 | Lippert et al. | Sep 2021 | A1 |
20210307766 | Keating et al. | Oct 2021 | A1 |
20210346656 | Lippert et al. | Nov 2021 | A1 |
20220039644 | Dayton et al. | Feb 2022 | A1 |
20220047845 | Niederhauser et al. | Feb 2022 | A1 |
20220105312 | Davis | Apr 2022 | A1 |
20220105318 | Davis et al. | Apr 2022 | A1 |
20220118225 | Snyder et al. | Apr 2022 | A1 |
20220176075 | Mcdermott et al. | Jun 2022 | A1 |
20220218358 | Dagan et al. | Jul 2022 | A1 |
20220273474 | Koop et al. | Sep 2022 | A1 |
20220280147 | Davis | Sep 2022 | A1 |
20220296850 | Lippert | Sep 2022 | A1 |
20220323166 | Tilson et al. | Oct 2022 | A1 |
20220378459 | Lippert | Dec 2022 | A1 |
20230010697 | Sharma et al. | Jan 2023 | A1 |
20230069698 | Hallauer et al. | Mar 2023 | A1 |
20230071512 | Maggio et al. | Mar 2023 | A1 |
20230082226 | Lippert et al. | Mar 2023 | A1 |
20230285720 | Isogai | Sep 2023 | A1 |
20230405276 | Cabiri | Dec 2023 | A1 |
20240123196 | Lippert et al. | Apr 2024 | A1 |
20240198059 | Lippert et al. | Jun 2024 | A1 |
20240299710 | Davis et al. | Sep 2024 | A1 |
Number | Date | Country |
---|---|---|
0723040 | Aug 2000 | AU |
733966 | May 2001 | AU |
0774559 | Jul 2004 | AU |
2008229892 | Oct 2008 | AU |
9709363 | Jan 2000 | BR |
9712829 | Jan 2000 | BR |
2255781 | Nov 1997 | CA |
2266685 | Mar 1998 | CA |
2395149 | Jun 2001 | CA |
1225282 | Aug 1999 | CN |
1230914 | Oct 1999 | CN |
1324285 | Nov 2001 | CN |
1422673 | Jun 2003 | CN |
1518428 | Aug 2004 | CN |
1781684 | Jun 2006 | CN |
1897892 | Jan 2007 | CN |
101001660 | Jul 2007 | CN |
101209365 | Jul 2008 | CN |
101304778 | Nov 2008 | CN |
201239164 | May 2009 | CN |
101815553 | Aug 2010 | CN |
102049085 | May 2011 | CN |
102107041 | Jun 2011 | CN |
102548603 | Jul 2012 | CN |
102639303 | Aug 2012 | CN |
102824681 | Dec 2012 | CN |
102847225 | Jan 2013 | CN |
103301553 | Sep 2013 | CN |
103764012 | Apr 2014 | CN |
103860265 | Jun 2014 | CN |
104271035 | Jan 2015 | CN |
104427950 | Mar 2015 | CN |
104602616 | May 2015 | CN |
104602718 | May 2015 | CN |
104759022 | Jul 2015 | CN |
105209102 | Dec 2015 | CN |
105361918 | Mar 2016 | CN |
105545375 | May 2016 | CN |
105582611 | May 2016 | CN |
105682725 | Jun 2016 | CN |
105682729 | Jun 2016 | CN |
105828690 | Aug 2016 | CN |
105979880 | Sep 2016 | CN |
107206216 | Sep 2017 | CN |
109125889 | Jan 2019 | CN |
109715245 | May 2019 | CN |
109789296 | May 2019 | CN |
60036882 | Jul 2008 | DE |
69738235 | Jul 2008 | DE |
0521595 | Jan 1993 | EP |
0921754 | Jun 1999 | EP |
0998323 | May 2000 | EP |
0934141 | Nov 2005 | EP |
1239901 | Oct 2007 | EP |
1844911 | Oct 2007 | EP |
1940498 | Jul 2008 | EP |
2964305 | Jan 2016 | EP |
2414022 | Aug 2017 | EP |
2293660 | Mar 2008 | ES |
2478988 | Sep 2011 | GB |
59-102509 | Jun 1984 | JP |
06-154335 | Jun 1994 | JP |
07-008560 | Jan 1995 | JP |
08-215313 | Aug 1996 | JP |
08-243169 | Sep 1996 | JP |
08-308934 | Nov 1996 | JP |
09-288239 | Nov 1997 | JP |
11-294497 | Oct 1999 | JP |
2000-116787 | Apr 2000 | JP |
2000-126301 | May 2000 | JP |
2000-511094 | Aug 2000 | JP |
2000-343313 | Dec 2000 | JP |
2001-500808 | Jan 2001 | JP |
2002-543896 | Dec 2002 | JP |
2003-011117 | Jan 2003 | JP |
2004-025340 | Jan 2004 | JP |
2004-136121 | May 2004 | JP |
2004-329552 | Nov 2004 | JP |
2004-535233 | Nov 2004 | JP |
2005-514115 | May 2005 | JP |
2005-533594 | Nov 2005 | JP |
2005-534407 | Nov 2005 | JP |
2007-514458 | Jun 2007 | JP |
2007-313638 | Dec 2007 | JP |
2008-178656 | Aug 2008 | JP |
2008-536639 | Sep 2008 | JP |
2010-029736 | Feb 2010 | JP |
2010-503484 | Feb 2010 | JP |
2010-535583 | Nov 2010 | JP |
2010-535588 | Nov 2010 | JP |
2011-206175 | Oct 2011 | JP |
4805208 | Nov 2011 | JP |
4845313 | Dec 2011 | JP |
2012-502743 | Feb 2012 | JP |
2012-522607 | Sep 2012 | JP |
2013-106854 | Jun 2013 | JP |
2013-523282 | Jun 2013 | JP |
2013-176560 | Sep 2013 | JP |
2014-023727 | Feb 2014 | JP |
2015-073861 | Apr 2015 | JP |
2015-181723 | Oct 2015 | JP |
2015-186427 | Oct 2015 | JP |
2016-013269 | Jan 2016 | JP |
2017-169253 | Sep 2017 | JP |
2000-0015896 | Mar 2000 | KR |
10-2000-0036139 | Jun 2000 | KR |
2017570 | Apr 2018 | NL |
91674 | Feb 2010 | RU |
412468 | Nov 2000 | TW |
9406503 | Mar 1994 | WO |
9419039 | Sep 1994 | WO |
9524237 | Sep 1995 | WO |
9743949 | Nov 1997 | WO |
9855173 | Dec 1998 | WO |
9858697 | Dec 1998 | WO |
9904847 | Feb 1999 | WO |
9953824 | Oct 1999 | WO |
2004011076 | Feb 2004 | WO |
2006025931 | Mar 2006 | WO |
2006058234 | Jun 2006 | WO |
2006113863 | Oct 2006 | WO |
2007050718 | May 2007 | WO |
2008034010 | Mar 2008 | WO |
2009020691 | Feb 2009 | WO |
2009020836 | Feb 2009 | WO |
2009020961 | Feb 2009 | WO |
2009020962 | Feb 2009 | WO |
2009143160 | Nov 2009 | WO |
2010077692 | Jul 2010 | WO |
2010115163 | Oct 2010 | WO |
2011123689 | Oct 2011 | WO |
2014005095 | Jan 2014 | WO |
2014066104 | May 2014 | WO |
2014138580 | Sep 2014 | WO |
2016047499 | Mar 2016 | WO |
2016117238 | Jul 2016 | WO |
2016136609 | Sep 2016 | WO |
2016152194 | Sep 2016 | WO |
2016158671 | Oct 2016 | WO |
2017151292 | Sep 2017 | WO |
2018017349 | Jan 2018 | WO |
2018017351 | Jan 2018 | WO |
2018218216 | Nov 2018 | WO |
2020217171 | Oct 2020 | WO |
2022159139 | Jul 2022 | WO |
Entry |
---|
Final Office Action received for U.S. Appl. No. 16/281,046, mailed on May 11, 2021, 18 pages. |
International Search Report and Written Opinion for PCT/US2019/021031 mailed on Jun. 18, 2019. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/14656, mailed on Apr. 28, 2021, 8 pages. |
Final Office Action received for U.S. Appl. No. 16/742,211, mailed on Mar. 14, 2023, 22 pages. |
Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Dec. 8, 2022, 18 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/053647, mailed on Dec. 28, 2021, 9 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/053652, mailed on Dec. 28, 2021, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 17/177,782, mailed on Jan. 23, 2023, 14 pages. |
Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Sep. 22, 2021, 12 pages. |
Final Office Action received for U.S. Appl. No. 16/616,220, mailed on Oct. 12, 2022, 17 pages. |
Final Office Action received for U.S. Appl. No. 17/216,127, mailed on Jun. 13, 2022, 8 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US21/042753, mailed on Nov. 5, 2021, 14 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/616,139, mailed on Oct. 26, 2021, 11 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/616,220, mailed on Jun. 3, 2022, 20 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/742,211, mailed on Aug. 15, 2022, 20 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jul. 11, 2022, 13 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jun. 23, 2021, 15 pages. |
Non-Final Office Action received for U.S. Appl. No. 17/177,782, mailed on Nov. 4, 2022, 7 pages. |
Final Office Action received for U.S. Appl. No. 12/753,831, mailed on May 31, 2012. |
Final Office Action received for U.S. Appl. No. 12/753,836 mailed on Feb. 17, 2016. |
Final Office Action received for U.S. Appl. No. 16/212,425, mailed on Aug. 3, 2020, 14 pages. |
Final Office Action received for U.S. Appl. No. 12/753,831, mailed on Aug. 29, 2014. |
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on Jan. 9, 2015. |
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on May 1, 2012. |
Final Office Action received for U.S. Appl. No. 12/753,849, mailed on Jun. 6, 2012. |
Final Office Action received for U.S. Appl. No. 12/753,849, mailed on Oct. 9, 2013. |
Final Office Action received for U.S. Appl. No. 12/753,855, mailed on Apr. 18, 2012. |
Final Office Action received for U.S. Appl. No. 12/753,855, mailed on Jan. 13, 2015. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Jan. 17, 2014. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Jul. 18, 2012. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on May 28, 2015. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 19, 2011. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 20, 2017. |
Final Office Action received for U.S. Appl. No. 12/753,836, mailed on Jul. 14, 2017. |
Final Office Action received for U.S. Appl. No. 15/606,607 mailed on Nov. 19, 2019. |
Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Aug. 27, 2020, 13 pages. |
Final Office Action received for U.S. Appl. No. 12/753,858, mailed on Nov. 14, 2018. |
Final Office Action received for U.S. Appl. No. 12/753,839 mailed on May 31, 2012. |
Final Office Action received for U.S. Appl. No. 14/199,675, mailed on May 18, 2017. |
Final Office Action received for U.S. Appl. No. 15/611,328, mailed on Sep. 24, 2019. |
Final Office Action received for U.S. Appl. No. 15/611,344, mailed on Nov. 12, 2019. |
Final Office Action received for U.S. Appl. No. 15/698,553, mailed on Nov. 27, 2019. |
Final Rejection received for U.S. Appl. No. 15/606,607, mailed on Dec. 15, 2020, 24 pages. |
International Search Report and Written Opinion for application No. PCT/US17/41299 dated Oct. 2, 2017. |
International Search Report and Written Opinion for application No. PCT/US17/41301 dated Oct. 2, 2017. |
International Search Report and Written Opinion for application No. PCT/US17/41305 dated Oct. 2, 2017. |
International Search Report and Written Opinion for Application PCT/US2017/050602 mailed on Nov. 7, 2017. |
International Search Report and Written Opinion for application PCT/US2017/050802 dated Nov. 7, 2017. |
International Search Report and Written Opinion for application PCT/US2017/050802 mailed on Nov. 7, 2017. |
International Search Report and Written Opinion for PCT/US2009/067217 dated Dec. 16, 2010. |
International Search Report and Written Opinion for PCT/US2010/029867 dated Jun. 1, 2010. |
International Search Report and Written Opinion for PCT/US2014/021742 dated Aug. 27, 2014. |
International Search Report and Written Opinion for PCT/US2017/041299 mailed on Oct. 2, 2017. |
International Search Report and Written Opinion for PCT/US2017/041301 mailed on Oct. 2, 2017. |
International Search Report and Written Opinion for PCT/US2017/068056 mailed on Feb. 26, 2018. |
International Search Report and Written Opinion for PCT/US2018/034723 dated Sep. 5, 2018. |
International Search Report and Written Opinion for PCT/US2018/034756 mailed on Aug. 14, 2018. |
International Search Report and Written Opinion for PCT/US2019/019046, mailed on May 17, 2019. |
International Search Report and Written Opinion issued in PCT/US2018/034723 mailed Sep. 5, 2018. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2020/030589, mailed on Jul. 17, 2020, 7 pages. |
International Search Report and Written Opinion, PCT App. No. PCT/US2020/013754, mailed on Jun. 9, 2020, 11 pages. |
Non-Final Office Action received for U.S. Appl. No. 15/606,607, mailed on Jun. 10, 2020, 26 pages. |
Non-Final Office Action received for U.S. Appl. No. 15/611,328, mailed on Jun. 29, 2020, 13 pages. |
Non-Final Office Action received for U.S. Appl. No. 15/917,255, mailed on Aug. 17, 2020, 12 pages. |
Non-Final Office Action received for U.S. Appl. No. 16/281,046, mailed on Oct. 29, 2020, 18 pages. |
Office Action received for U.S. Appl. No. 12/633,727, mailed on Oct. 16, 2012. |
Non-Final Office Action received for U.S. Appl. No. 15/848,878, mailed on Jun. 3, 2021, 13 pages. |
Office Action received for European Patent Application No. 19710207.2, mailed on Dec. 4, 2023, 4 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US22/42514, mailed on Dec. 28, 2022, 11 pages. |
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US22/42517, mailed on Feb. 7, 2023, 11 pages. |
Supplementary European Search Report received for EP Patent Application No. 21744674.9, mailed on Feb. 7, 2024, 9 pages. |
Office Action received for U.S. Appl. No. 12/753,831, mailed on Feb. 1, 2012. |
Office Action received for U.S. Appl. No. 12/753,831, mailed on Mar. 21, 2014. |
Office Action received for U.S. Appl. No. 12/753,836, mailed on Dec. 9, 2011. |
Office Action received for U.S. Appl. No. 12/753,836, mailed on Dec. 23, 2016. |
Office Action received for U.S. Appl. No. 12/753,836, mailed on Jul. 31, 2014. |
Office Action received for U.S. Appl. No. 12/753,836, mailed on Jun. 26, 2015. |
Office Action received for U.S. Appl. No. 12/753,839, mailed on May 5, 2014. |
Office Action received for U.S. Appl. No. 12/753,842, mailed on Jan. 29, 2014. |
Office Action received for U.S. Appl. No. 12/753,849, mailed on Jan. 3, 2013. |
Office Action received for U.S. Appl. No. 12/753,849, mailed on May 10, 2011. |
Office Action received for U.S. Appl. No. 12/753,849, mailed on May 27, 2014. |
Office Action received for U.S. Appl. No. 12/753,849, mailed on Oct. 18, 2011. |
Office Action received for U.S. Appl. No. 12/753,855, mailed on Feb. 28, 2014. |
Office Action received for U.S. Appl. No. 12/753,855, mailed on May 21, 2015. |
Office Action received for U.S. Appl. No. 12/753,855, mailed on Sep. 15, 2011. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Dec. 30, 2015. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Feb. 3, 2012. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 13, 2018. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 27, 2017. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Mar. 29, 2013. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on May 10, 2011. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Oct. 24, 2016. |
Office Action received for U.S. Appl. No. 12/753,858, mailed on Sep. 4, 2014. |
Office Action received for U.S. Appl. No. 13/901,375, mailed on Aug. 1, 2016. |
Office Action received for U.S. Appl. No. 13/901,375, mailed on Dec. 10, 2015. |
Office Action received for U.S. Appl. No. 15/606,607 mailed on May 14, 2019. |
Office Action received for U.S. Appl. No. 15/611,344, mailed on May 21, 2020. |
Office Action received for U.S. Appl. No. 15/698,553, mailed on Nov. 27, 2019. |
Office Action received for U.S. Appl. No. 15/848,878, mailed on Feb. 5, 2020. |
Office Action received for U.S. Appl. No. 16/212,425, mailed on Mar. 16, 2020. |
Office Action received for U.S. Appl. No. 12/753,855 mailed on May 5, 2016. |
Office Action received for U.S. Appl. No. 14/199,675, mailed on Nov. 3, 2016. |
Office Action received for U.S. Appl. No. 15/465,399, mailed on Apr. 23, 2018. |
Office Action received for U.S. Appl. No. 15/611,328, mailed on Mar. 27, 2019. |
Office Action received for U.S. Appl. No. 15/611,344, mailed on Mar. 26, 2019. |
Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership, Jul. 14, 2020, https://investors.penumbrainc.com/investors-relations/press-releases/press-release-details/2020/Penumbra-Augments-Vascular-Franchise-with-Latest-Indigo-System-Launch-and-Expands-MedicalScientific-Leadership/default.aspx. |
U.S. Appl. No. 12/753,839, filed Feb. 7, 2012, Office Action. |
U.S. Appl. No. 12/753,839, filed May 31, 2012, Final Office Action. |
U.S. Appl. No. 12/753,842, filed Aug. 1, 2012, Office Action. |
U.S. Appl. No. 12/753,842, filed Jan. 9, 2013, Final Office Action. |
U.S. Appl. No. 12/753,842, filed Sep. 4, 2014, Final Office Action. |
U.S. Appl. No. 12/753,858, filed May 28, 2015, Final Office Action. |
Final Office Action received for U.S. Appl. No. 16/855,366, mailed on Jun. 20, 2024, 17 pages. |
Final Office Action received for U.S. Appl. No. 17/836,863, mailed on Jun. 25, 2024, 6 pages. |
Non-Final Office Action received for U.S. Appl. No. 17/382,271, mailed on May 14, 2024, 22 pages. |
Non-Final Office Action received for U.S. Appl. No. 17/493,265, mailed on Jun. 11, 2024, 19 pages. |
European Search Report received for EP Patent Application No. 21878402, mailed on Aug. 14, 2024, 13 pages. |
Final Office Action received for U.S. Appl. No. 17/382,271, mailed on Sep. 16, 2024, 9 pages. |
Non-Final Office Action received for U.S. Appl. No. 17/752,600, mailed on Sep. 10, 2024, 11 pages. |
Requirement for Restriction/Election received for U.S. Appl. No. 17/493,281, mailed on Oct. 9, 2024, 13 pages. |
Number | Date | Country | |
---|---|---|---|
20210228845 A1 | Jul 2021 | US |
Number | Date | Country | |
---|---|---|---|
62965005 | Jan 2020 | US |